NCT00309894View on ClinicalTrials.gov

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions

Prostate Cancer

Interventions

BIOLOGICAL

sargramostim

DRUG

ketoconazole

DRUG

therapeutic hydrocortisone

Trial Locations (2)

94115

UCSF Comprehensive Cancer Center, San Francisco

94121

Veterans Affairs Medical Center - San Francisco, San Francisco

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00309894 - Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | Biotech Hunter | Biotech Hunter